Reviewer Guidelines ( update)

Reviewer Guidelines

Double-anonymised  review is the reviewing system followed in Iraqi Journal of Pharmaceutical Science. All the steps of reviewing are fully electronic. The reviewers have to read the criteria for judging a submission's suitability for publication in the journal , which may include instructions for preparing an effective and helpful review. Reviewers will have an opportunity to provide comments intended for the author and editors as well as separate comments for the editor only within maximum three weeks as  a First round . Reviewers will be asked to comply with the competing interests disclosure policy.

 

Reviewer Guidelines

Manuscript evaluation form

ID number: (used in all steps of publication):  (             )

Manuscript title:

  1. Manuscript publication:

1-1 Has the manuscript been published  anywhere ??

Yes                       No 

If your answer is yes, please specify the reference.

  1. Scientific Quality

2-1 Does the abstract provide a concise and complete summary?

Yes                       No 

2-2 Does the introduction cover the previous studies and aim of the present study?

Yes                       No 

2-3 Is the language fluent and precise ?

Yes                       No 

2-4 Are the number and quality of references appropriate?

Yes                       No 

2-5 Are the figures and tables correctly defined and used?

Yes                       No 

2-6 Is the overall presentation well structured and clear?

Good        Fair       Poor

  1. Scientific Significance:

3-1 Is the manuscript original work that reflects research undertaken with integrity and honesty?

Yes                       No 

3-2 Does the manuscript present novel concepts, ideas?

Yes                       No 

3-2 Does the manuscript represent a substantial contribution to scientific progress?

Yes                       No 

Notes and revisions required: Please make a recommendation (Accept; Accept with revisions; Submit for review; Submit  elsewhere; Decline; See comments).

Please view the PDF  file for the review process.